Review
Open access
Jul 2026
Progress on novel compounds for the treatment of bone metabolism-related disorders: focus on osteoporosis and beyond
Bone metabolism-related disorders represent a significant global health burden, due to their high prevalence and substantial socioeconomic costs, particularly osteoporosis. Conventional antiresorptive and anabolic agents have well-established clinical utility, such as bisphosphonates, denosumab, teriparatide, and romos...
Yeqiong Song, Rui-Xin Zhang, Xin-Yu Zhang et al.
· Frontiers in Chemistry · 0 citations